UBS clients raise $650m for biggest biotech impact fund
UBS's wealthy clients have raised $650 million for the biggest biotechnology impact fund ever. The Oncology Impact Fund 2, run by biotechnology...
UBS's wealthy clients have raised $650 million for the biggest biotechnology impact fund ever. The Oncology Impact Fund 2, run by biotechnology...